Ubs Asset Management Americas Inc Pliant Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 117,482 shares of PLRX stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117,482
Previous 72,119
62.9%
Holding current value
$1.24 Million
Previous $1.07 Million
17.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PLRX
# of Institutions
158Shares Held
63.8MCall Options Held
481KPut Options Held
105K-
Deep Track Capital, LP Greenwich, CT5.97MShares$63 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$52.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.6MShares$48.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$36.3 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.4MShares$35.9 Million3.33% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $514M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...